Surgical resection with lymphadenectomy is the mainstay of treatment for all resectable esophagogastric junction tumors, prior to systemic generalization of the disease. This makes accurate pre-treatment staging and classification of the tumors most demanding. A wellestablished and internationally accepted classification for adenocarcinomas of the esophagogastric junction (AEG)helps to choose the appropriate surgical approach and to make results from different institutions comparable.Distal esophageal adenocarcinomas (AEG I) are distinguished from true cardia carcinomas (AEG Ⅱ)and subcardiac gastric cancers (AEG Ⅲ). Substantial advancements in this surgical field during the preceding decades have clearly revealed that individualization of the surgical strategy is the key to successfully approaching these entities. In this review we discuss the surgical management of esophagogastric junction tumors with a tailored surgical strategy.